Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07066813

Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces

T-Staging Strategies and Their Prognostic and Therapeutic Significance in Lung Cancer With Cystic Airspaces: A Retrospective Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Central South University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to determine the most accurate tumor size measurement method for T-staging and prognostic assessment in lung cancer with cystic airspaces (LCCA). The main questions it aims to answer are: * What is the optimal T-staging approach for accurately classifying lung cancer with cystic airspaces (LCCA) and predicting patient outcomes? * How do imaging features of cystic lesions correlate with their pathological characteristics? * What is the relationship between imaging features of cystic airspace-associated lesions and patient prognosis? * Can optimizing the T-staging method improve clinical decision-making in patients with LCCA?

Conditions

Timeline

Start date
2025-06-01
Primary completion
2026-05-31
Completion
2026-07-01
First posted
2025-07-15
Last updated
2026-03-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07066813. Inclusion in this directory is not an endorsement.